Ipsen is a global specialty-driven pharmaceutical company and also has a significant presence in consumer healthcare. Our ambition is to become a leader in the treatment of targeted debilitating diseases.
Ipsen at a glance
Ipsen is a global specialty-driven pharmaceutical group with total sales exceeding €1.6 billion in 2016. Ipsen sells more than 20 drugs in more than 115 countries, with a direct commercial presence in more than 30 countries worldwide. The Group has more than 5,100 employees all over the world.
Our strategy is to build a global biopharma company focused on innovation and specialty care which delivers differentiated therapeutics to meet unmet patient needs.
Since it was founded in 1929, by Henri Beaufour, Ipsen has developed, and made available to patients, a number of products in Oncology, Neuroscience, Rare Diseases and Consumer Healthcare. Global footprint, acquisitions, partnerships, scientific collaborations and innovations: learn about the development of our group over the years.
Ipsen is firmly anchored in the international market with a direct commercial presence in more than 30 countries. Use our interactive map to find information on our locations around the world.